- Home
- EDIT vs AVNW Comparison
EDIT vs AVNW Comparison
Compare EDIT & AVNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDIT
- AVNW
- Stock Information
- Founded
- EDIT 2013
- AVNW 2006
- Country
- EDIT United States
- AVNW United States
- Employees
- EDIT N/A
- AVNW N/A
- Industry
- EDIT Biotechnology: Biological Products (No Diagnostic Substances)
- AVNW Radio And Television Broadcasting And Communications Equipment
- Sector
- EDIT Health Care
- AVNW Technology
- Exchange
- EDIT Nasdaq
- AVNW Nasdaq
- Market Cap
- EDIT 241.9M
- AVNW 274.4M
- IPO Year
- EDIT 2016
- AVNW 2007
- Fundamental
- Price
- EDIT $2.69
- AVNW $23.91
- Analyst Decision
- EDIT Buy
- AVNW Strong Buy
- Analyst Count
- EDIT 12
- AVNW 5
- Target Price
- EDIT $5.40
- AVNW $37.60
- AVG Volume (30 Days)
- EDIT 1.3M
- AVNW 125.3K
- Earning Date
- EDIT 11-03-2025
- AVNW 09-10-2025
- Dividend Yield
- EDIT N/A
- AVNW N/A
- EPS Growth
- EDIT N/A
- AVNW N/A
- EPS
- EDIT N/A
- AVNW 0.10
- Revenue
- EDIT $38,901,000.00
- AVNW $434,606,000.00
- Revenue This Year
- EDIT N/A
- AVNW $7.15
- Revenue Next Year
- EDIT N/A
- AVNW $6.61
- P/E Ratio
- EDIT N/A
- AVNW $239.10
- Revenue Growth
- EDIT N/A
- AVNW 6.50
- 52 Week Low
- EDIT $0.91
- AVNW $12.96
- 52 Week High
- EDIT $4.12
- AVNW $26.83
- Technical
- Relative Strength Index (RSI)
- EDIT 51.07
- AVNW 56.53
- Support Level
- EDIT $2.56
- AVNW $22.07
- Resistance Level
- EDIT $2.84
- AVNW $23.20
- Average True Range (ATR)
- EDIT 0.17
- AVNW 1.07
- MACD
- EDIT 0.00
- AVNW 0.22
- Stochastic Oscillator
- EDIT 58.82
- AVNW 49.68
About EDIT Editas Medicine Inc.
Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.
About AVNW Aviat Networks Inc.
Aviat Networks Inc is a networking solutions provider. It designs, manufactures and sells wireless networking products, solutions, and services to mobile and fixed operators, private network operators, government agencies, transportation and utility companies, public safety agencies, and broadcast network operators around the world. The company's product categories include point-to-point microwave and millimeter wave radios that are licensed (subject to local frequency regulatory requirements), lightly licensed and license-exempt (operating in license-exempt frequencies), and element and network management software.